Large-scale testing (Phase 3)Study completedNCT00095654
What this trial is testing
The DREAM (Diabetes Reduction Assessment With Ramipril and Rosiglitazone Medication) Trial
Who this might be right for
Impaired Glucose ToleranceCardiovascular DiseaseGlucose Metabolism Disorders
Gerstein, Hertzel, MD 5,000